THERAPY OF LOWER-EXTREMITY INFECTIONS WITH CIPROFLOXACIN IN PATIENTS WITH DIABETES-MELLITUS, PERIPHERAL VASCULAR-DISEASE, OR BOTH

被引:120
作者
PETERSON, LR
LISSACK, LM
CANTER, K
FASCHING, CE
CLABOTS, C
GERDING, DN
机构
[1] VET ADM MED CTR,MED SERV,PODIATRY SECT,MINNEAPOLIS,MN 55417
[2] VET ADM MED CTR,LAB SERV,MICROBIOL SECT,MINNEAPOLIS,MN 55417
关键词
D O I
10.1016/0002-9343(89)90476-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:801 / 808
页数:8
相关论文
共 40 条
[11]   CIPROFLOXACIN, A QUINOLONE CARBOXYLIC-ACID COMPOUND ACTIVE AGAINST AEROBIC AND ANAEROBIC-BACTERIA [J].
CHIN, NX ;
NEU, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (03) :319-326
[12]   INVITRO ACTIVITY OF EFROTOMYCIN, CIPROFLOXACIN, AND 6 OTHER ANTIMICROBIALS AGAINST CLOSTRIDIUM-DIFFICILE [J].
CLABOTS, CR ;
SHANHOLTZER, CJ ;
PETERSON, LR ;
GERDING, DN .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1987, 6 (01) :49-52
[13]   HIGH-PRESSURE LIQUID-CHROMATOGRAPHY OF (BAY O 9867) CIPROFLOXACIN IN SERUM SAMPLES [J].
FASCHING, CE ;
PETERSON, LR .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1985, 8 (03) :555-562
[14]   THERAPEUTIC IMPLICATIONS OF BACTERIOLOGIC FINDINGS IN MIXED AEROBIC-ANAEROBIC INFECTIONS [J].
FINEGOLD, SM ;
WEXLER, HM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (05) :611-616
[15]   CIPROFLOXACIN CONCENTRATIONS IN BONE AND MUSCLE AFTER ORAL DOSING [J].
FONG, IW ;
LEDBETTER, WH ;
VANDENBROUCKE, AC ;
SIMBUL, M ;
RAHM, V .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (03) :405-408
[16]   CIPROFLOXACIN PHARMACOKINETICS IN PATIENTS WITH NORMAL AND IMPAIRED RENAL-FUNCTION [J].
GASSER, TC ;
EBERT, SC ;
GRAVERSEN, PH ;
MADSEN, PO .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (05) :709-712
[17]  
GIBBONS GW, 1984, MANAGEMENT DIABETIC, P97
[18]   TREATMENT OF BONE, JOINT, AND SOFT-TISSUE INFECTIONS WITH ORAL CIPROFLOXACIN [J].
GREENBERG, RN ;
KENNEDY, DJ ;
REILLY, PM ;
LUPPEN, KL ;
WEINANDT, WJ ;
BOLLINGER, MR ;
AGUIRRE, F ;
KODESCH, F ;
SAEED, AMK .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (02) :151-155
[19]  
GUAY DRP, 1987, AM J MED, V82, P124
[20]  
HUGHES C E, 1987, Clinical Therapeutics, V10, P36